Social media rumours about asymptomatic Covid-19 patients not spreading the infection is not backed by research, a top UAE official has said.
“This is a new disease and there have been limited studies. We need to continue taking precautions, wear masks, and act as if everyone may be infected,” said Dr Farida Al Hosani, official spokesperson for the UAE Health Sector.
During the virtual Press briefing about developments related to Covid-19 on Wednesday, Amna Al Dhahak Al Shamsi, UAE Government spokesperson, said the world is seeing “positive indicators”. “But that doesn’t mean the pandemic is over and that we can fully return to normal life. It is our responsibility to continue adhering to the precautions while adapting to a new lifestyle.”
Efficacy of rapid tests, hydroxychloroquine
Dr Farida said rapid anti-body tests lack accuracy and “is currently being assessed”.
When asked if hydroxychloroquine was effective, the official said: “Trials of various medications are underway. We had mixed reports regarding hydroxychloroquine. We are currently using it on mild and moderate cases and not on critical ones. This is in line with global practices. It is a safe drug with no side effects.”
She added that the UAE is studying the use of hydroxychloroquine and “will share the results soon”.
Stem cell treatment
Dr Fatima Al Kaabi, head of hematology and oncology department at Sheikh Khalifa Medical City and research assistant of the Stem Cell Project, said the UAE’s breakthrough stem cell therapy has secured IPR (intellectual property rights) so that it can be used extensively.
She said those who received the treatment recovered in seven days – three times faster than those receiving conventional treatment.
“The treatment was administered to 72 patients with moderate to severe symptoms. The immunity response of every patient was assessed. The study excluded cancer patients, those with under 10 haemoglobin level, and those aged under 18.”
